Synthesis and Anti‐HIV‐1 Activity of New Fluoro‐HEPT Analogues: An Investigation on Fluoro versus Hydroxy Substituents
暂无分享,去创建一个
[1] Yasser M Loksha. Novel synthetic route for 5-substituted 6-arylmethylluracils from 2,4,6-trichloropyrimidines , 2009 .
[2] R. Loddo,et al. Synthesis and Antiviral Evaluation of 6‐(Trifluoromethylbenzyl) and 6‐(Fluorobenzyl) Analogues of HIV Drugs Emivirine and GCA‐186 , 2007, Archiv der Pharmazie.
[3] K. Danel,et al. Synthesis and antiviral activity of new dimeric inhibitors against HIV-1. , 2008, Bioorganic & medicinal chemistry.
[4] Ying Guo,et al. The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors. , 2007, Bioorganic & medicinal chemistry.
[5] C. Salomon,et al. Rationally designed dual inhibitors of HIV reverse transcriptase and integrase. , 2007, Journal of medicinal chemistry.
[6] E. De Clercq,et al. Non-nucleoside HIV-1 reverse transcriptase inhibitors, Part 7. Synthesis, antiviral activity, and 3D-QSAR investigations of novel 6-(1-naphthoyl) HEPT analogues. , 2006, Chemical & pharmaceutical bulletin.
[7] S. Gayen,et al. QSAR study on some anti-HIV HEPT analogues using physicochemical and topological parameters. , 2004, Bioorganic & medicinal chemistry.
[8] C. Nielsen,et al. Synthesis of 6-arylvinyl analogues of the HIV drugs SJ-3366 and Emivirine. , 2004, Bioorganic & medicinal chemistry.
[9] L. Agrofoglio,et al. Palladium-assisted routes to nucleosides. , 2003, Chemical reviews.
[10] Michal Hocek. Syntheses of Purines Bearing Carbon Substituents in Positions 2, 6 or 8 by Metal- or Organometal-Mediated C−C Bond-Forming Reactions , 2003 .
[11] P. T. Jørgensen,et al. Synthesis of novel N-1 (allyloxymethyl) analogues of 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (MKC-442, emivirine) with improved activity against HIV-1 and its mutants. , 2002, Journal of medicinal chemistry.
[12] P. T. Jørgensen,et al. Synthesis of New MKC-442 Analogues Containing Alkenyl Chains or Reactive Functionalities at C-5 , 2002 .
[13] V. Gevorgyan,et al. Can agostic interaction affect regiochemistry of carbopalladation? Reverse regioselectivity in the palladium-catalyzed dimerization of aryl acetylenes. , 2001, Journal of the American Chemical Society.
[14] E. Pedersen,et al. Three Routes for the Synthesis of 6-Benzyl-1-ethoxymethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde , 2001 .
[15] J. Liddle,et al. Synthesis and pharmacology of the isomeric methylheptyl-Δ8-tetrahydrocannabinols , 1998 .
[16] S Shigeta,et al. Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro , 1994, Antimicrobial Agents and Chemotherapy.
[17] M. Baba,et al. Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442. , 1993, Molecular pharmacology.
[18] H. Mitsuya,et al. Molecular targets for AIDS therapy. , 1990, Science.
[19] R T Walker,et al. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. , 1989, Biochemical and biophysical research communications.
[20] R T Walker,et al. A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. , 1989, Journal of medicinal chemistry.
[21] J Desmyter,et al. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. , 1988, Journal of virological methods.
[22] D W Barry,et al. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[23] H. Vorbrüggen,et al. Nucleoside syntheses, XXII1) Nucleoside synthesis with trimethylsilyl triflate and perchlorate as catalysts , 1981 .